Cutis; cutaneous medicine for the practitioner 2012-02-01

Clobetasol propionate spray 0.05% for the treatment of moderate to severe plaque psoriasis.

Alan Menter

Index: Cutis. 89(2) , 89-94, (2012)

Full Text: HTML

Abstract

Clobetasol propionate is a super-high potent class 1 topical corticosteroid available in several formulations, including a spray formulation that is approved for use up to 4 weeks in patients aged 18 years and older with moderate to severe plaque psoriasis. The efficacy and safety of clobetasol propionate spray 0.05% has been extensively evaluated in clinical trials in more than 2200 patients with moderate to severe plaque psoriasis. This article reviews the efficacy, safety, and tolerability of clobetasol propionate spray 0.05%. Clobetasol propionate spray 0.05% is a topical product with a documented efficacy and safety profile with good acceptability in patients with moderate to severe plaque psoriasis.


Related Compounds

Related Articles:

Curcumin relieves TPA-induced Th1 inflammation in K14-VEGF transgenic mice.

2015-04-01

[Int. Immunopharmacol. 25(2) , 235-41, (2015)]

Topical steroids for chronic wounds displaying abnormal inflammation.

2013-05-01

[Ann. R. Coll. Surg. Engl. 95(4) , 291-6, (2013)]

Impact of clobetasol propionate 0.05% spray on health-related quality of life in patients with plaque psoriasis.

2012-11-01

[Journal. of. Drugs in. Dermatology. 11(11) , 1348-54, (2012)]

Influence of the type of vegetable oil on the drug release profile from lipid-core nanocapsules and in vivo genotoxicity study.

2014-11-01

[Pharm. Dev. Technol. 19(7) , 789-98, (2014)]

Beefy red plaques in the perianal region.

2014-04-01

[JAMA Dermatol. 150(4) , 447-8, (2014)]

More Articles...